- Home
- KNSA vs TBLA Comparison
KNSA vs TBLA Comparison
Compare KNSA & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- TBLA
- Stock Information
- Founded
- KNSA 2015
- TBLA 2007
- Country
- KNSA United Kingdom
- TBLA United States
- Employees
- KNSA N/A
- TBLA N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- TBLA Computer Software: Programming Data Processing
- Sector
- KNSA Health Care
- TBLA Technology
- Exchange
- KNSA Nasdaq
- TBLA Nasdaq
- Market Cap
- KNSA 1.4B
- TBLA 1.2B
- IPO Year
- KNSA 2018
- TBLA N/A
- Fundamental
- Price
- KNSA $20.02
- TBLA $3.71
- Analyst Decision
- KNSA Strong Buy
- TBLA Strong Buy
- Analyst Count
- KNSA 5
- TBLA 5
- Target Price
- KNSA $36.60
- TBLA $5.25
- AVG Volume (30 Days)
- KNSA 567.6K
- TBLA 680.7K
- Earning Date
- KNSA 02-25-2025
- TBLA 02-26-2025
- Dividend Yield
- KNSA N/A
- TBLA N/A
- EPS Growth
- KNSA N/A
- TBLA N/A
- EPS
- KNSA N/A
- TBLA N/A
- Revenue
- KNSA $384,098,000.00
- TBLA $1,694,954,000.00
- Revenue This Year
- KNSA $60.10
- TBLA $24.12
- Revenue Next Year
- KNSA $34.22
- TBLA $15.72
- P/E Ratio
- KNSA N/A
- TBLA N/A
- Revenue Growth
- KNSA 54.41
- TBLA 21.84
- 52 Week Low
- KNSA $16.56
- TBLA $2.87
- 52 Week High
- KNSA $28.15
- TBLA $4.96
- Technical
- Relative Strength Index (RSI)
- KNSA 53.15
- TBLA 43.37
- Support Level
- KNSA $19.31
- TBLA $3.81
- Resistance Level
- KNSA $20.20
- TBLA $4.01
- Average True Range (ATR)
- KNSA 0.80
- TBLA 0.11
- MACD
- KNSA 0.06
- TBLA -0.02
- Stochastic Oscillator
- KNSA 72.80
- TBLA 17.81
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About TBLA Taboola.com Ltd.
Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, Germany, France, Rest of the world whilst it generates the majority of its revenue from the United States.